Developmental control of CFTR: from bioinformatics to novel therapeutic approaches.
journal contributionposted on 21.03.2022, 16:26 authored by Catherine GreeneCatherine Greene, Dominik Hartl
miRNA-binding blocker oligonucleotides offer an appealing option for developing tools to correct CFTR function http://ow.ly/AjS8a
Comments“This is an author-submitted, peer-reviewed version of a manuscript that has been accepted for publication in the European Respiratory Journal, prior to copy-editing, formatting and typesetting. This version of the manuscript may not be duplicated or reproduced without prior permission from the copyright owner, the European Respiratory Society. The publisher is not responsible or liable for any errors or omissions in this version of the manuscript or in any version derived from it by any other parties. The final, copy-edited, published article, which is the version of record, is available without a subscription 18 months after the date of issue publication.”
Published CitationGreene CM, Hartl D. Developmental control of CFTR: from bioinformatics to novel therapeutic approaches. European Respiratory Journal. 2015;45(1):18-20
- Beaumont Hospital